Ruconest Global Market Report 2025

Ruconest Global Market Report 2025 – By Product (Injectable Ruconest, Intravenous Ruconest), By Dosage Form (Powder For Reconstitution, Pre-Filled Syringes), By Clinical Indication (Hereditary Angioedema (HAE) Acute Attacks, Hereditary Angioedema (HAE) Prophylaxis, Other Angioedema-related Conditions), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies), By End-User (Hospitals, Specialty Clinics, Ambulatory Care, Home Care) – Market Size, Trends, And Global Forecast 2025-2034

Name: Ruconest Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Ruconest Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

Ruconest Market Definition

Ruconest is a recombinant human C1 esterase inhibitor designed to treat acute attacks of hereditary angioedema (HAE). It helps alleviate swelling and inflammation by supplementing the body's deficient or malfunctioning C1 inhibitor. It is administered intravenously and offers fast relief from the symptoms of HAE attacks.

The main product types of ruconest are injectable ruconest and intravenous ruconest. Injectable ruconest is a lyophilized powder for injection that treats acute hereditary angioedema (HAE) attacks by replacing deficient or dysfunctional C1 esterase inhibitors. It is available in different dosage forms, such as powder for reconstitution and pre-filled syringes, for several types of clinical indications, including hereditary angioedema (HAE) acute attacks, hereditary angioedema (HAE) prophylaxis, and other angioedema-related conditions. It is distributed through various distribution channels, such as hospital pharmacies and retail pharmacies, by several end-users, including hospitals, specialty clinics, ambulatory care, and home care.

Ruconest Market Segmentation

The ruconestmarket covered in this report is segmented –

1) By Product: Injectable Ruconest, Intravenous Ruconest

2) By Dosage Form: Powder For Reconstitution, Pre-Filled Syringes

3) By Clinical Indication: Hereditary Angioedema (HAE) Acute Attacks, Hereditary Angioedema (HAE) Prophylaxis, Other Angioedema-related Conditions

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies

5) By End-User: Hospitals, Specialty Clinics, Ambulatory Care, Home Care

Ruconest Market Size and growth rate 2025 to 2029: Graph

Ruconest Market Size 2025 And Growth Rate

The ruconest market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to awareness initiatives related to HAE, the increasing prevalence of hereditary angioedema, the increasing shift toward personalized medicine, the advancement in targeted therapies for HAE, and expanding physician prescriber base.

Ruconest Market Growth Forecast

The ruconest market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to advancements in diagnostic technologies, rising awareness levels for hereditary angioedema, increasing Research & Development and funding for orphan drug development, increasing awareness among healthcare professionals, and demand for subcutaneous injections. Major trends in the forecast period include advancements in targeted therapies, development of new complement inhibitors, increasing use of digital platforms, rise in recombinant biologics, and shift toward personalized medicine.

Book your 30 minutes free consultation with our research experts

Ruconest Market Driver: Rising Prevalence Of Hereditary Angioedema (HAE) To Drive Ruconest Market Growth

The growing prevalence of hereditary angioedema (HAE) is expected to propel the growth of the ruconest market going forward. Hereditary angioedema (HAE) is a rare genetic disorder characterized by recurrent episodes of severe swelling in various parts of the body, including the face, extremities, and airway. The growing prevalence of hereditary angioedema (HAE) is due to a deficiency or malfunction of the C1 inhibitor (C1-INH), a protein essential for controlling the immune system's inflammatory responses. Ruconest, a recombinant human C1 esterase inhibitor, is highly effective in treating Hereditary Angioedema (HAE) by rapidly restoring deficient or dysfunctional C1-INH levels, thereby reducing the frequency and severity of swelling episodes associated with this rare genetic disorder. For instance, in June 2022, according to Rare Disease Advisor, a US-based online resource for the latest rare disease news, hereditary angioedema (HAE) affects approximately 1 in 50,000 individuals globally, with prevalence rates ranging between 1 in 10,000 and 1 in 150,000. In the U.S., HAE leads to 15,000 to 30,000 emergency department visits annually. Therefore, the growing prevalence of hereditary angioedema Therefore, the growing prevalence of hereditary angioedema (HAE) is driving the growth of the ruconest market.

Ruconest Market Driver: Growing Shift Toward Personalized Medicine To Drive Ruconest Market Growth

The increasing shift toward personalized medicine is expected to propel the growth of the ruconest market going forward. Personalized medicine is a healthcare strategy that customizes treatments and medical decisions based on a person's genetic makeup, environmental influences, and lifestyle. The demand for personalized medicine is increasing due to advancements in genomics, growing awareness of individualized healthcare, and improvements in diagnostic technologies. Ruconest plays a key role in personalized medicine by offering targeted treatment for hereditary angioedema (HAE) through a recombinant C1 esterase inhibitor. This tailored approach optimizes treatment based on individual patient needs, improving symptom management and reducing attack severity. For instance, in February 2024, according to the Personal Medicine Coalition, a US-based non-profit organization, in 2023, FDA approvals for personalized medicine rose from 34% in 2022 to 38%, reflecting a growing trend in adopting treatments tailored to individual genetic profiles. Therefore, an increasing shift toward personalized medicine is driving the growth of the Ruconest market.

Ruconest Market Driver: Rising Healthcare Expenditure Driving Growth In The Ruconest Market

The increasing healthcare expenditure is expected to propel the growth of the ruconest market going forward. Healthcare expenditure refers to the overall financial resources allocated for healthcare services, products, and infrastructure during a defined period. The increasing healthcare expenditure is due to several factors, including advancements in medical technology, higher healthcare prices, and public health initiatives. Healthcare expenditure plays a pivotal role in supporting Ruconest by enabling increased access to advanced treatments for rare genetic conditions such as Hereditary Angioedema (HAE), fostering research and development, and ensuring coverage for innovative therapies that improve patient outcomes. For instance, in November 2023, according to the Canadian Institute for Health Information, a Canada-based non-profit organization, total health expenditure is projected to reach $344 billion in 2023, reflecting a modest growth of 2.8% compared to the previous year. Therefore, increasing healthcare expenditure is driving the growth of the ruconest market.

Global Ruconest Market Major Players

Major companies operating in the ruconest market include Pharming Group N.V.

Regional Outlook For The Global Ruconest Market

North America was the largest region in the ruconest market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ruconest market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the ruconest market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Ruconest Market?

The ruconest market consists of sales of biologic drugs and recombinant c1 esterase inhibitors. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Ruconest Industry?

The ruconest market research report is one of a series of new reports from The Business Research Company that provides ruconest market statistics, including the ruconest industry global market size, regional shares, competitors with the ruconest market share, detailed ruconest market segments, market trends, and opportunities, and any further data you may need to thrive in the ruconest industry. This ruconest market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Ruconest Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	CAGR of from 2025 to 2034
Revenue Forecast In 2034	2024
Growth Rate	2019-2024
Base Year For Estimation	2025 - 2029 - 2034
Actual Estimates/Historical Data	Revenue in USD Billion and CAGR from 2025 to 2034
Forecast Period	1) By Product: Injectable Ruconest, Intravenous Ruconest 2) By Dosage Form: Powder For Reconstitution, Pre-Filled Syringes 3) By Clinical Indication: Hereditary Angioedema (HAE) Acute Attacks, Hereditary Angioedema (HAE) Prophylaxis, Other Angioedema-related Conditions 4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies 5) By End-User: Hospitals, Specialty Clinics, Ambulatory Care, Home Care
Market Representation	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Segments Covered	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Regional Scope	Pharming Group N.V.
Country Scope	Request for Sample
Key Companies Profiled	Explore Purchase Options
Customization Scope
Pricing And Purchase Options

1. Executive Summary

2. Ruconest Market Characteristics

3. Ruconest Market Biologic Drug Characteristics

3.1. Molecule Type

3.2. Route Of Administration (ROA)

3.3. Mechanism Of Action (MOA)

3.4. Safety And Efficacy

4. Ruconest Market Trends And Strategies

5. Ruconest Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

6. Global Ruconest Growth Analysis And Strategic Analysis Framework

6.1. Global Ruconest PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

6.2. Analysis Of End Use Industries

6.3. Global Ruconest Market Growth Rate Analysis

6.4. Global Ruconest Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

6.5. Global Ruconest Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

6.6. Global Ruconest Total Addressable Market (TAM)

7. Global Ruconest Market Pricing Analysis & Forecasts

8. Ruconest Market Segmentation

8.1. Global Ruconest Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Injectable Ruconest

Intravenous Ruconest

8.2. Global Ruconest Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Powder For Reconstitution

Pre-Filled Syringes

8.3. Global Ruconest Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hereditary Angioedema (HAE) Acute Attacks

Hereditary Angioedema (HAE) Prophylaxis

Other Angioedema-related Conditions

8.4. Global Ruconest Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital Pharmacies

Retail Pharmacies

8.5. Global Ruconest Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Speciality Clinics

Ambulatory Care

Home Care

9. Global Ruconest Market Epidemiology Of Clinical Indications

9.1. Drug Side Effects

9.2. Incidence And Prevalence of Clinical Indications

10. Ruconest Market Regional And Country Analysis

10.1. Global Ruconest Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. Global Ruconest Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Asia-Pacific Ruconest Market

11.1. Asia-Pacific Ruconest Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Ruconest Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Asia-Pacific Ruconest Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Asia-Pacific Ruconest Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. China Ruconest Market

12.1. China Ruconest Market Overview

12.2. China Ruconest Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

12.3. China Ruconest Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

12.4. China Ruconest Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

13. India Ruconest Market

13.1. India Ruconest Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. India Ruconest Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. India Ruconest Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. Japan Ruconest Market

14.1. Japan Ruconest Market Overview

14.2. Japan Ruconest Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. Japan Ruconest Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. Japan Ruconest Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Australia Ruconest Market

15.1. Australia Ruconest Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.2. Australia Ruconest Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Australia Ruconest Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. South Korea Ruconest Market

16.1. South Korea Ruconest Market Overview

16.2. South Korea Ruconest Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. South Korea Ruconest Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.4. South Korea Ruconest Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Western Europe Ruconest Market

17.1. Western Europe Ruconest Market Overview

17.2. Western Europe Ruconest Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Western Europe Ruconest Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.4. Western Europe Ruconest Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. UK Ruconest Market

18.1. UK Ruconest Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. UK Ruconest Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. UK Ruconest Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Germany Ruconest Market

19.1. Germany Ruconest Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Germany Ruconest Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Germany Ruconest Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. France Ruconest Market

20.1. France Ruconest Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. France Ruconest Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. France Ruconest Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Ruconest Market

21.1. Eastern Europe Ruconest Market Overview

21.2. Eastern Europe Ruconest Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Ruconest Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Ruconest Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. North America Ruconest Market

22.1. North America Ruconest Market Overview

22.2. North America Ruconest Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. North America Ruconest Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.4. North America Ruconest Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. USA Ruconest Market

23.1. USA Ruconest Market Overview

23.2. USA Ruconest Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. USA Ruconest Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. USA Ruconest Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. Canada Ruconest Market

24.1. Canada Ruconest Market Overview

24.2. Canada Ruconest Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. Canada Ruconest Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. Canada Ruconest Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. South America Ruconest Market

25.1. South America Ruconest Market Overview

25.2. South America Ruconest Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. South America Ruconest Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. South America Ruconest Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. Middle East Ruconest Market

26.1. Middle East Ruconest Market Overview

26.2. Middle East Ruconest Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. Middle East Ruconest Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. Middle East Ruconest Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Africa Ruconest Market

27.1. Africa Ruconest Market Overview

27.2. Africa Ruconest Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Africa Ruconest Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.4. Africa Ruconest Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Ruconest Market Competitive Landscape And Company Profiles

28.1. Ruconest Market Competitive Landscape

28.2. Ruconest Market Company Profiles

28.2.1. Pharming Group N.V. Overview, Products and Services, Strategy and Financial Analysis

29. Global Ruconest Market Pipeline Analysis

29.1. High Level Clinic Trail Information

30. Global Ruconest Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Ruconest Market

32. Recent Developments In The Ruconest Market

33. Ruconest Market High Potential Countries, Segments and Strategies

33.1 Ruconest Market In 2029 - Countries Offering Most New Opportunities

33.2 Ruconest Market In 2029 - Segments Offering Most New Opportunities

33.3 Ruconest Market In 2029 - Growth Strategies

33.3.1 Market Trend Based Strategies

33.3.2 Competitor Strategies

34. Appendix

34.1. Abbreviations

34.2. Currencies

34.3. Historic And Forecast Inflation Rates

34.4. Research Inquiries

34.5. The Business Research Company

34.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Ruconest Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Ruconest Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Ruconest Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Ruconest Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Ruconest Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Ruconest Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Ruconest Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Asia-Pacific, Ruconest Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Asia-Pacific, Ruconest Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Ruconest Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: China, Ruconest Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: China, Ruconest Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Ruconest Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: India, Ruconest Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: India, Ruconest Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Ruconest Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: Japan, Ruconest Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: Japan, Ruconest Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Ruconest Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Australia, Ruconest Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Australia, Ruconest Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Ruconest Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: South Korea, Ruconest Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: South Korea, Ruconest Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: South Korea, Ruconest Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Western Europe, Ruconest Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Western Europe, Ruconest Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Western Europe, Ruconest Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: UK, Ruconest Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: UK, Ruconest Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: UK, Ruconest Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Germany, Ruconest Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Germany, Ruconest Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: Germany, Ruconest Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: France, Ruconest Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: France, Ruconest Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: France, Ruconest Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Eastern Europe, Ruconest Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Eastern Europe, Ruconest Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: Eastern Europe, Ruconest Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: North America, Ruconest Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: North America, Ruconest Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: North America, Ruconest Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: USA, Ruconest Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: USA, Ruconest Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: USA, Ruconest Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Canada, Ruconest Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Canada, Ruconest Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Canada, Ruconest Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: South America, Ruconest Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: South America, Ruconest Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: South America, Ruconest Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Middle East, Ruconest Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Middle East, Ruconest Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Middle East, Ruconest Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: Africa, Ruconest Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: Africa, Ruconest Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: Africa, Ruconest Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: Pharming Group N.V. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Ruconest Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Ruconest Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Ruconest Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Ruconest Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Ruconest Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Ruconest Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Ruconest Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Asia-Pacific, Ruconest Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Asia-Pacific, Ruconest Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Ruconest Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: China, Ruconest Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: China, Ruconest Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Ruconest Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: India, Ruconest Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: India, Ruconest Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Ruconest Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: Japan, Ruconest Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: Japan, Ruconest Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Ruconest Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Australia, Ruconest Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Australia, Ruconest Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Ruconest Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: South Korea, Ruconest Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: South Korea, Ruconest Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: South Korea, Ruconest Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Western Europe, Ruconest Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Western Europe, Ruconest Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Western Europe, Ruconest Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: UK, Ruconest Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: UK, Ruconest Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: UK, Ruconest Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Germany, Ruconest Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Germany, Ruconest Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: Germany, Ruconest Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: France, Ruconest Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: France, Ruconest Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: France, Ruconest Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Eastern Europe, Ruconest Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Eastern Europe, Ruconest Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: Eastern Europe, Ruconest Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: North America, Ruconest Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: North America, Ruconest Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: North America, Ruconest Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: USA, Ruconest Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: USA, Ruconest Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: USA, Ruconest Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Canada, Ruconest Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Canada, Ruconest Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Canada, Ruconest Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: South America, Ruconest Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: South America, Ruconest Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: South America, Ruconest Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Middle East, Ruconest Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Middle East, Ruconest Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Middle East, Ruconest Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: Africa, Ruconest Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: Africa, Ruconest Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: Africa, Ruconest Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: Pharming Group N.V. Financial Performance

Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company

Global Gene Therapy Market 2022 – Market Opportunities And Strategies

The Microbiome Market Share, Market Size, And Growth Rate 2022

The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the insulin drugs market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the kidney cancer drugs market research report 2022 with industry size, share, segments and market growth

Enzyme Inhibitor Global Market Report 2025 – By Type (Proton Pump Inhibitors (PPIs), Protease Inhibitors, Reverse Transcriptase Inhibitors, Aromatase Inhibitors, Kinase Inhibitors, Neuraminidase Inhibitors, Statins, Other Types), By Disease Indication (Chronic Obstructive Pulmonary Disorders, Cardiovascular Disease, Gastrointestinal Disorders, Arthritis, Inflammatory Diseases, Other Disease Indications), By Application (Chemotherapy, Antibiotics, Pesticides, Cardiovascular Treatments, Other Applications), By End User (Pharmaceutical, Biotechnology, Food and Beverage, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Tumor Necrosis Factor Inhibitor Drugs Global Market Report 2025 – By Product Type (Humira, Enbrel, Remicade, Simponi/Simponi Aria, Cimzia, Biosimilars ), By Route Of Administration (Subcutaneous Injection, Intravenous Injection ), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies ), By Application (Rheumatoid Arthritis, Psoriasis, Psoriatic Arthritis, Crohn’s Disease, Ulcerative Colitis, Ankylosing Spondylitis, Juvenile Idiopathic Arthritis, Hidradenitis Suppurativa, Other Applications ) – Market Size, Trends, And Global Forecast 2025-2034

View Report

ACE Inhibitors Global Market Report 2025 – By Type (Sulfhydryl-containing Agents, Dicarboxylate-containing Agents, Phosphonate-containing Agents), By Drug (Ramipril, Enalapril, Benazepril, Fosinopril, Captopril, Moexipril, Other Drugs), By Dosage Form (Oral Tablets, Oral Solutions), By Application (Heart Failure, Chronic Kidney Disease, Hypertension, Diabetes, Heart Attack, Other Applications), By End-Users (Hospitals, Online Drug Stores, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

mTOR Inhibitors Global Market Report 2025 – By Product Type (Rapamune, Afinitor, Torisel, Zortress, Other Product Types), By Indication (Oncology, Immunosuppressant, Organ Transplantation, Other Indications), By Route of Administration (Oral, Intravenous), By Application (Tumor Treatment, Kidney Transplant, Other Applications), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2025-2034

View Report

PD-1 and PDL1 Inhibitors/ Immune Checkpoint Inhibitors Global Market Report 2025 – By Product (Nivolumab, Pembrolizumab, Atezolizumab, Avelumab, Durvalumab), By Distribution Channel (Hospital pharmacies, Retail pharmacies, Online pharmacies), By Application (Lung Cancer, Bladder Cancer, Melanoma, Hodgkin Lymphoma, Colorectal Cancer, Other Applications), By End-Users (Hospitals, Specialty Clinics, Academic and Research Institutions) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Proton Pump Inhibitors Global Market Report 2025 – By Type (Pantoprazole, Omeprazole, Lansoprazole, Esomeprazole, Rabeprazole, Dexlansoprazole, Other Types), By Disease Allocation (Ulcers, Gastroesophageal Reflux Disease, Other Disease Indications), By Application (Hospitals, Clinic, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Checkpoint Inhibitors Global Market Report 2025 – By Drug (PD-1 Inhibitors, PD-L1 Inhibitors, CTLA-4, Chimeric Antigen Receptor T-cell, Other Drugs), By Application (Lung Cancer, Renal Cancer, Blood Cancer, Bladder Cancer, Melanoma, Other Applications), By End-Users (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Interleukin Inhibitors Global Market Report 2025 – By Type (IL-17, IL-23, IL-1, IL-5, IL-6, Other Types), By Application (Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis, Asthma, Inflammatory Bowel Disease, Other Applications), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Ruconest market?

How will the Ruconest market drivers and restraints affect the market dynamics? What forces will shape the Ruconest industry going forward?

The Ruconest market major growth driver - Rising Prevalence Of Hereditary Angioedema (HAE) To Drive Ruconest Market Growth. For further insights on the Ruconest market, request a sample here

What is the forecast market size or the forecast market value of the Ruconest market?

The Ruconest market size has grown strongly in recent years. The ruconest market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to awareness initiatives related to HAE, the increasing prevalence of hereditary angioedema, the increasing shift toward personalized medicine, the advancement in targeted therapies for HAE, and expanding physician prescriber base. The ruconest market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to advancements in diagnostic technologies, rising awareness levels for hereditary angioedema, increasing Research & Development and funding for orphan drug development, increasing awareness among healthcare professionals, and demand for subcutaneous injections. Major trends in the forecast period include advancements in targeted therapies, development of new complement inhibitors, increasing use of digital platforms, rise in recombinant biologics, and shift toward personalized medicine. For further insights on the Ruconest market, request a sample here

How is the Ruconest market segmented?

The ruconestmarket covered in this report is segmented –
1) By Product: Injectable Ruconest; Intravenous Ruconest
2) By Dosage Form: Powder For Reconstitution; Pre-Filled Syringes
3) By Clinical Indication: Hereditary Angioedema (HAE) Acute Attacks; Hereditary Angioedema (HAE) Prophylaxis; Other Angioedema-related Conditions
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies
5) By End-User: Hospitals; Specialty Clinics; Ambulatory Care; Home Care For further insights on the Ruconest market, request a sample here

Which region has the largest share of the Ruconest market? What are the other regions covered in the report?

Who are the major players in the Ruconest market?

Major companies operating in the ruconest market include Pharming Group N.V. . For further insights on the Ruconest market, request a sample here.

What are the key trends in the Ruconest market?

Major trends in the Ruconest market include . For further insights on the Ruconest market, request a sample here.

What are the major opportunities in the Ruconest market? What are the strategies for the Ruconest market?

For detailed insights on the major opportunities and strategies in the Ruconest market, request a sample here.

How does the Ruconest market relate to the overall economy and other similar markets?

For detailed insights on Ruconest's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Ruconest industry?

For detailed insights on the mergers and acquisitions in the Ruconest industry, request a sample here.

What are the key dynamics influencing the Ruconest market growth? SWOT analysis of the Ruconest market.

For detailed insights on the key dynamics influencing the Ruconest market growth and SWOT analysis of the Ruconest industry, request a sample here.